Intravenous and intra-arterial administration of bone marrow mononuclear cells after focal cerebral ischemia: Is there a difference in biodistribution and efficacy?

Stem Cell Research

Volumn 9, Issue 1, 2012, Pages 1-8

  Vasconcelos dos Santos, Andréia ^a,b   Rosado de Castro, Paulo Henrique ^a,b   Lopes de Souza, Sergio Augusto ^a   Da Costa Silva, Juliana ^a   Ramos, Alane Bernardo ^a   Rodriguez de Freitas, Gabriel ^a   Barbosa da Fonseca, Lea Mirian ^a   Gutfilen, Bianca ^a   Mendez Otero, Rosalia ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia de Biologia Estrutural e Bioimagem INBEB   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN; BRAIN ISCHEMIA; CELL HOMING; CELL LABELING; CELL TRACKING; CELLULAR DISTRIBUTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; HISTOLOGY; INTERMETHOD COMPARISON; INTRAARTERIAL BONE MARROW MONONUCLEAR CELL ADMINISTRATION; INTRAVENOUS BONE MARROW MONONUCLEAR CELL ADMINISTRATION; LIVER; LUNG; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BONE MARROW TRANSPLANTATION; BRAIN ISCHEMIA; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; MONOCYTES; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 84858743385     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2012.02.002     Document Type: Article

References (33)

1. Bacigaluppi M., Pluchino S., Peruzzotti-Jametti L., Kilic E., Kilic U., Salani G., Brambilla E., West M.J., Comi G., Martino G., Hermann D.M. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 2009, 132:2239-2251.
2. Baker A.H., Sica V., Work L.M., Williams-Ignarro S., de Nigris F., Lerman L.O., Casamassimi A., Lanza A., Schiano C., Rienzo M., Ignarro L.J., Napoli C. Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3597-3602.
3. Barbosa da Fonseca L.M., Gutfilen B., Rosado de Castro P.H., Battistella V., Goldenberg R.C., Kasai-Brunswick T., Chagas C.L., Wajnberg E., Maiolino A., Salles Xavier S., Andre C., Mendez-Otero R., de Freitas G.R. Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Exp. Neurol. 2010, 221:122-128.
4. Battistella V., de Freitas G.R., da Fonseca L.M., Mercante D., Gutfilen B., Goldenberg R.C., Dias J.V., Kasai-Brunswick T.H., Wajnberg E., Rosado-de-Castro P.H., Alves-Leon S.V., Mendez-Otero R., André C. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen. Med. 2011, 6:45-52.
5. Borlongan C.V., Hadman M., Sanberg C.D., Sanberg P.R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004, 35:2385-2389.
6. Brenneman M., Sharma S., Harting M., Strong R., Cox C.S., Aronowski J., Grotta J.C., Savitz S.I. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J. Cereb. Blood Flow Metab. 2010, 30:140-149.
7. Carvalho A.B., Quintanilha L.F., Dias J.V., Paredes B.D., Mannheimer E.G., Carvalho F.G., Asensi K.D., Gutfilen B., Fonseca L.M., Resende C.M., Rezende G.F., Takiya C.M., de Carvalho A.C., Goldenberg R.C. Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 2008, 26:1307-1314.
8. de Vasconcelos Dos Santos A., da Costa Reis J., Diaz Paredes B., Moraes L., Giraldi-Guimarães Jasmin A., Mendez-Otero R. Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Res. 2010, 1306:149-158.
9. Detante O., Moisan A., Dimastromatteo J., Richard M.J., Riou L., Grillon E., Barbier E., Desruet M.D., De Fraipont F., Segebarth C., Jaillard A., Hommel M., Ghezzi C., Remy C. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplant. 2009, 18:1369-1379.
10. Fischer U.M., Harting M.T., Jimenez F., Monzon-Posadas W.O., Xue H., Savitz S.I., Laine G.A., Cox C.S. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009, 18:683-692.
11. Gao J., Dennis J.E., Muzic R.F., Lundberg M., Caplan A.I. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001, 169:12-20.
12. Garcia L.P., Montenegro M.M.S., Ramalho W.M. Mortalidade no Brasil: Situação de 2008 e evolução segundo principais grupos de causas no período de 1980 a 2008 2009, Ministério da Saude.
13. Giraldi-Guimaraes A., Rezende-Lima M., Bruno F.P., Mendez-Otero R. Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res. 2009, 1266:108-120.
14. Hicks A.U., Lappalainen R.S., Narkilahti S., Suuronen R., Corbett D., Sivenius J., Hovatta O., Jolkkonen J. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur. J. Neurosci. 2009, 29:562-574.
15. Iihoshi S., Honmou O., Houkin K., Hashi K., Kocsis J.D. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res. 2004, 1007:1-9.
16. Kamiya N., Ueda M., Igarashi H., Nishiyama Y., Suda S., Inaba T., Katayama Y. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci. 2008, 83:433-437.
17. Kaufmann T.J., Huston J., Mandrekar J.N., Schleck C.D., Thielen K.R., Kallmes D.F. Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology 2007, 243:812-819.
18. Lappalainen R.S., Narkilahti S., Huhtala T., Liimatainen T., Suuronen T., Narvanen A., Suuronen R., Hovatta O., Jolkkonen J. The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci. Lett. 2008, 440:246-250.
19. Lassance R.M., Prota L.F., Maron-Gutierrez T., Garcia C.S., Abreu S.C., Pássaro C.P., Xisto D.G., Castiglione R.C., Carreira H., Ornellas D.S., Santana M.C., Souza S.A., Gutfilen B., Fonseca L.M., Rocco P.R., Morales M.M. Intratracheal instillation of bone marrow-derived cell in an experimental model of silicosis. Respir. Physiol. Neurobiol. 2009, 169:227-233.
20. Li L., Jiang Q., Ding G., Zhang L., Zhang Z.G., Li Q., Panda S., Lu M., Ewing J.R., Chopp M. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J. Cereb. Blood Flow Metab. 2010, 30:653-662.
21. Lindvall O., Kokaia Z. Stem cells in human neurodegenerative disorders-time for clinical translation?. J. Clin. Invest. 2010, 120:29-40.
22. Lotufo P.A., Bensenor I.M. Stroke mortality in Brazil: one example of delayed epidemiological cardiovascular transition. Int. J. Stroke 2009, 4:40-41.
23. Mendez-Otero R., de Freitas G.R., André C., de Mendonça M.L., Friedrich M., Oliveira-Filho J. Potential roles of bone marrow stem cells in stroke therapy. Regen. Med. 2007, 2:417-423.
24. Mendonça M.L., Freitas G.R., Silva S.A., Manfrim A., Falcão C.H., Gonzáles C., André C., Dohmann H.F., Borojevic R., Otero R.M. Safety of intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke. Arq. Bras. Cardiol. 2006, 86:52-55.
25. Nakano-Doi A., Nakagomi T., Fujikawa M., Nakagomi N., Kubo S., Lu S., Yoshikawa H., Soma T., Taguchi A., Matsuyama T. Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells 2010, 28:1292-1302.
26. Ohtaki H., Ylostalo J.H., Foraker J.E., Robinson A.P., Reger R.L., Shioda S., Prockop D.J. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14638-14643.
27. Quintanilha L.F., Mannheimer E.G., Carvalho A.B., Paredes B.D., Dias J.V., Almeida A.S., Gutfilen B., Barbosa da Fonseca L.M., Resende C.M., Rezende G.F., Campos de Carvalho A.C., Goldenberg R.C. Bone marrow cell transplant does not prevent or reverse murine liver cirrhosis. Cell Transplant. 2008, 17:943-953.
28. Schallert T. Behavioral tests for preclinical intervention assessment. NeuroRx 2006, 3:497-504.
29. Schallert T., Woodlee M.T., Fleming S.M. Pharmacology of Cerebral Ischemia 2001, Medpharm Scientific Publishers, Stuttgart.
30. Schwarting S., Litwak S., Hao W., Bahr M., Weise J., Neumann H. Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 2008, 39:2867-2875.
31. Shimada I.S., Spees J.L. Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics. J. Cell. Biochem. 2011, 112:374-380.
32. Szele F.G., Alexander C., Chesselet M.F. Expression of molecules associated with neuronal plasticity in the striatum after aspiration and thermocoagulatory lesions of the cerebral cortex in adult rats. J. Neurosci. 1995, 15:4429-4448.
33. Walczak P., Zhang J., Gilad A.A., Kedziorek D.A., Ruiz-Cabello J., Young R.G., Pittenger M.F., van Zijl P.C., Huang J., Bulte J.W. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008, 39:1569-1574.